U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 3

Figure 3. From: Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.

A: Transmission electron micrographs of HepG2 cells from the control group( EM , original magnification × 6200); B: Transmission electron micrographs of HepG2 cells from the αIR3 group (EM, original magnification × 6200).

You-Cheng Zhang, et al. World J Gastroenterol. 2006 Jul 7;12(25):3977-3982.
2.
Figure 1

Figure 1. From: Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.

A: Immunohistochemical findings of IGF-IR in Chang liver cells. Chang liver cells showing positive-staining of IGF-IR in the cell membranes of the cells (SABC, original magnification × 100); B: Immunohistochemical findings of IGF-IR in HepG2 cells. HepG2 cells showing stronger positive-staining of IGF-IR in the cell membranes of the cells than that of Chang liver cells (SABC, original magnification× 100).

You-Cheng Zhang, et al. World J Gastroenterol. 2006 Jul 7;12(25):3977-3982.
3.
Figure 2

Figure 2. From: Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.

Effects of αIR3 on in vitro growth of HepG2 cells treated with various concentrations of αIR3 for different periods of time. αIR3 of 0.1 μg/mL could stimulate HepG2 cells to proliferate, while αIR3 inhibited HepG2 cell proliferation in a dose- and time-dependent manner at a concentration ranging from 0.2 μg/mL to 4.0 μg/mL.

You-Cheng Zhang, et al. World J Gastroenterol. 2006 Jul 7;12(25):3977-3982.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center